Not Found
On Demand

Common Skin Issues & Medical Cannabis in Texas


Total Credits: 2 including 2 AOA Category 1-A Credit(s)

Average Rating:
Not yet rated
State Associations:
TOMA - Texas
Faculty:
Rick Lin |  Matthew Atwood
Duration:
2 Hours 09 Minutes
Expiration:
Never expires.


Description

Common Skin Conditions
Rick Lin, DO, MPH, FACOD, FAAD
This session will provide an overview of various dermatology conditions for physicians practicing in primary care fields.

Objectives:
  1. Discuss new information on the pathophysiology of common dermatologic diseases
  2. Outline management plans for specific cases of dermatologic diseases
  3. Explain in therapy based on clinical response, potential side effects, and appropriate monitoring of specific therapies.
 

Medical Cannabis in Texas
Matt Atwood
There seems to be more misinformation than information about medical cannabis in the LoneStar State. In this presentation, you will learn the basics in cannabinoid science, the political push-back, and the difference between what you think you know and what you should know. After this presentation, you will have a better knowledge base to make more of an educated decision on your own personal and professional stance on this controversial topic.

Objectives:
  1. Differentiate between fact and fiction, politics and medicine
  2. Feel confident discussing medical cannabis with patients when they ask
  3. Feel comfortable about the plant and endocannabinoid system
  4. Open your mind regarding the medical possibilities ahead
 
The Texas Osteopathic Medical Association (TOMA) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. TOMA designates this program for a maximum of 2.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Handouts

Faculty

Rick Lin Related seminars and products: 2


Dr. Rick Lin is a board certified dermatologist practicing in McAllen, Texas since 2006.  Dr. Lin earned his Bachelor degree in Biology at the University of California at Berkeley and received his medical degree from the University of North Texas Health Science Center at Fort Worth in 2001.He also graduated with a Master’s in Public Health at the School of Public Health at the UNTHSC.  He then completed a traditional rotating internship at Dallas Southwest Medical Center in 2002.
In 2005 Dr. Lin completed his Dermatology residency training at the Northeast Regional Medical Center in Kirksville, Missouri in conjunction with the Dermatology Institute of North Texas.Dr. Lin is board certified by the American Osteopathic Board of Dermatology in the primary specialty of dermatology.  He also holds certification of added qualifications for Mohs Micrographic Surgery.In addition, he is also a board certified sub-specialist in Pediatric Dermatology.


Matthew Atwood Related seminars and products: 1


Matt Atwood has established a successful and multi-faceted career as an innovative sales and marketing leader, award-winning keynote speaker, healthcare medical diagnostics specialist and professional educator for corporate sales and management training (PSS). He has also been recognized as a creative visionary by developing of cutting edge ancillary medical programs that support “result-driven healthcare” and is responsible for developing and launching AllergyPro nationally in August 2016, and LoneStar Life Sciences in 2017, and AllergyFree in 2018.

Matt is also the visionary behind Lonestar Life Sciences, which will include subsidiary companies such as Lonestar AgriTech (hydroponics/aeroponics/aquaponics for proprietary SmartFarm, hops, and cannabis), Lonestar MedTech (healthcare division for AllergyFree, cultured stem cell lab, pharmaceutical grade phytobiologics) as well as preparing for Lonestar InfoTech (medical blockchain software division), LoneStar Institute for Functional & Environmental Medicine, and LoneStar Academy, a national education center for physicians and sales representatives.


Please wait ...

Back to Top